Graph Therapeutics Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 15

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $5M

  • Investors
  • 8

Graph Therapeutics General Information

Description

Developer of AI-driven precision medicine designed for perturbation modeling from primary patient cell samples combined with multi-omics data to deliver transformative targeted therapies and biomarkers for immune-driven diseases. The company leverages artificial intelligence to analyze a patient's unique biology to create personalized treatment plans for immune-mediated diseases, enabling the healthcare industry to overcome the unique challenges of developing therapies for complex inflammatory diseases.

Contact Information

Website
www.graphtx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Xista Science Park, Plöcking 1
  • Klosterneuburg, 3400
  • Austria
Primary Industry
Drug Discovery
Other Industries
Other Healthcare Technology Systems
Biotechnology
Corporate Office
  • Xista Science Park, Plöcking 1
  • Klosterneuburg, 3400
  • Austria

Graph Therapeutics Timeline

20252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Graph Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 22-Jun-2026 $5M Completed Generating Revenue
3. Grant 22-Apr-2025 Completed Generating Revenue
2. Grant 03-Mar-2025 $1.15M $3.1M Completed Generating Revenue
1. Seed Round 09-Jan-2025 $3.1M $3.1M Completed Generating Revenue
To view Graph Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Graph Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of AI-driven precision medicine designed for perturbation modeling from primary patient cell samples combined
Drug Discovery
Klosterneuburg, Austria
15 As of 2026

London, United Kingdom
 

Paris, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Graph Therapeutics Competitors (3)

One of Graph Therapeutics’s 3 competitors is Relation Therapeutics, a Venture Capital-Backed company based in London, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Relation Therapeutics Venture Capital-Backed London, United Kingdom
Owkin Venture Capital-Backed Paris, France
Recursion AI Corporation Palo Alto, CA
You’re viewing 3 of 3 competitors. Get the full list »

Graph Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Graph Therapeutics Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Daphni Venture Capital Minority
Austria Wirtschaftsservice Venture Capital Minority
Österreichische Forschungsförderungsgesellschaft Government
Angel (individual) Minority
Merantix Capital Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Graph Therapeutics FAQs

  • When was Graph Therapeutics founded?

    Graph Therapeutics was founded in 2024.

  • Where is Graph Therapeutics headquartered?

    Graph Therapeutics is headquartered in Klosterneuburg, Austria.

  • What is the size of Graph Therapeutics?

    Graph Therapeutics has 15 total employees.

  • What industry is Graph Therapeutics in?

    Graph Therapeutics’s primary industry is Drug Discovery.

  • Is Graph Therapeutics a private or public company?

    Graph Therapeutics is a Private company.

  • What is Graph Therapeutics’s current revenue?

    The current revenue for Graph Therapeutics is .

  • How much funding has Graph Therapeutics raised over time?

    Graph Therapeutics has raised $8.1M.

  • Who are Graph Therapeutics’s investors?

    Daphni, Austria Wirtschaftsservice, Österreichische Forschungsförderungsgesellschaft, , and Merantix Capital are 5 of 8 investors who have invested in Graph Therapeutics.

  • Who are Graph Therapeutics’s competitors?

    Relation Therapeutics, Owkin, and Recursion AI are competitors of Graph Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process